Stock MD PEDIATRIX MEDICAL GROUP, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Pediatrix Medical Group, Inc.

Equities

MD

US58502B1061

Healthcare Facilities & Services

Market Closed - Nyse
Other stock markets
 16:00:02 2024-06-25 EDT 		5-day change 1st Jan Change
7.65 USD -5.32% Intraday chart for Pediatrix Medical Group, Inc. -0.78% -17.74%
06-17 Pediatrix Medical Group, Inc. Eliminates Lee. A Wood as Executive Vice President, National and Market Operations, Effective as of July 5, 2024 CI
06-07 Deutsche Bank Upgrades Pediatrix Medical Group to Hold From Sell, $8 Price Target MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 2,306 2,058 2,319 1,217 770.3 633.3 - -
Enterprise Value (EV) 1 3,924 2,679 2,937 1,859 1,330 1,059 931.4 802.3
P/E ratio -1.55 x -2.57 x 17.8 x 18.8 x -12.7 x 9.27 x 7.54 x 7.12 x
Yield - - - - - - - -
Capitalization / Revenue 0.66 x 1.19 x 1.21 x 0.62 x 0.39 x 0.31 x 0.31 x 0.3 x
EV / Revenue 1.12 x 1.55 x 1.54 x 0.94 x 0.67 x 0.53 x 0.45 x 0.38 x
EV / EBITDA 7.84 x 12.2 x 11.1 x 7.71 x 6.64 x 5.26 x 4.46 x 3.76 x
EV / FCF 12.5 x 15.2 x 66 x - 12.8 x 12 x 9.62 x -
FCF Yield 8.02% 6.56% 1.51% - 7.82% 8.34% 10.4% -
Price to Book 1.56 x 2.81 x 2.62 x 1.38 x 0.92 x 0.68 x 0.62 x 0.58 x
Nbr of stocks (in thousands) 82,988 83,875 85,241 81,926 82,829 82,790 - -
Reference price 2 27.79 24.54 27.21 14.86 9.300 7.650 7.650 7.650
Announcement Date 20-02-20 21-02-18 22-02-17 23-02-17 24-02-20 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 3,514 1,734 1,911 1,972 1,995 2,014 2,057 2,136
EBITDA 1 500.8 219.9 265.5 241 200.4 201.2 208.6 213.5
EBIT 1 408.5 191.4 233.3 205.4 164.2 164.7 172.8 179.6
Operating Margin 11.63% 11.04% 12.21% 10.42% 8.23% 8.17% 8.4% 8.41%
Earnings before Tax (EBT) 1 -1,242 7.148 135.2 81.37 -48.36 103.4 118.1 129.1
Net income 1 -1,498 -796.5 131 66.34 -60.41 68.13 83.38 70.9
Net margin -42.63% -45.93% 6.85% 3.36% -3.03% 3.38% 4.05% 3.32%
EPS 2 -17.94 -9.550 1.530 0.7900 -0.7300 0.8250 1.015 1.075
Free Cash Flow 1 314.8 175.8 44.49 - 104 88.3 96.85 -
FCF margin 8.96% 10.14% 2.33% - 5.21% 4.38% 4.71% -
FCF Conversion (EBITDA) 62.85% 79.97% 16.76% - 51.89% 43.88% 46.42% -
FCF Conversion (Net income) - - 33.97% - - 129.6% 116.16% -
Dividend per Share 2 - - - - - - - -
Announcement Date 20-02-20 21-02-18 22-02-17 23-02-17 24-02-20 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 498.5 482.2 486 489.9 513.8 491 500.6 506.6 496.4 495.1 505 510.6 503.8 490.7 514
EBITDA 1 81.04 50.68 65.56 58.31 66.49 40.06 59.12 50.42 50.82 37.21 50.1 57.49 56.74 38.34 52.66
EBIT 1 73.18 41.91 56.78 49.35 57.35 31.1 50.18 40.27 41.76 26.9 41.4 49.2 47.44 27.15 43.74
Operating Margin 14.68% 8.69% 11.68% 10.07% 11.16% 6.33% 10.02% 7.95% 8.41% 5.43% 8.2% 9.64% 9.42% 5.53% 8.51%
Earnings before Tax (EBT) 1 53.52 -28.35 43.03 38.86 27.82 20.71 38.95 30.83 -138.8 7.824 26.01 33.63 34.51 19.44 32.62
Net income 1 47.52 -21.19 27.14 30.73 29.66 14.21 28.28 21.39 -124.3 4.035 17.05 21.66 23.42 12.44 22.8
Net margin 9.53% -4.39% 5.58% 6.27% 5.77% 2.89% 5.65% 4.22% -25.04% 0.81% 3.38% 4.24% 4.65% 2.53% 4.44%
EPS 2 0.5500 -0.2500 0.3200 0.3700 0.3600 0.1700 0.3400 0.2600 -1.500 0.0500 0.2075 0.2600 0.2850 0.1533 0.2750
Dividend per Share 2 - - - - - - - - - - - - - - -
Announcement Date 22-02-17 22-04-28 22-08-04 22-11-03 23-02-17 23-05-02 23-08-03 23-11-02 24-02-20 24-05-07 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 1,618 621 617 641 560 426 298 169
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 3.23 x 2.824 x 2.325 x 2.661 x 2.795 x 2.116 x 1.429 x 0.7913 x
Free Cash Flow 1 315 176 44.5 - 104 88.3 96.8 -
ROE (net income / shareholders' equity) 12.3% 7.04% 15.9% 15.7% 11.9% 11.4% 11.8% 10.7%
ROA (Net income/ Total Assets) 5.6% 2.11% 7.08% 5.52% 4.54% 4.8% 5.26% 5.25%
Assets 1 -26,758 -37,759 1,850 1,202 -1,332 1,419 1,586 1,351
Book Value Per Share 2 17.80 8.730 10.40 10.70 10.10 11.20 12.20 13.30
Cash Flow per Share 2 4.150 2.450 0.8900 - 1.670 1.390 1.880 2.020
Capex 1 31.9 28.8 32.2 - 33.3 28.9 29.7 28.8
Capex / Sales 0.91% 1.66% 1.69% - 1.67% 1.43% 1.44% 1.35%
Announcement Date 20-02-20 21-02-18 22-02-17 23-02-17 24-02-20 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Pediatrix Medical Group, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
8
Last Close Price
7.65 USD
Average target price
8.5 USD
Spread / Average Target
+11.11%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

1st Jan change Capi.
PEDIATRIX MEDICAL GROUP, INC. Stock Pediatrix Medical Group, Inc.
-17.74% 633M
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+25.78% 89.17B
CVS HEALTH CORPORATION Stock CVS Health Corporation
-23.45% 75.87B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
+3.45% 27.41B
LABCORP HOLDINGS INC. Stock Labcorp Holdings Inc.
-8.56% 17.52B
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
+0.68% 17.04B
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
+0.30% 15.36B
TENET HEALTHCARE CORPORATION Stock Tenet Healthcare Corporation
+78.55% 13.18B
NATERA, INC. Stock Natera, Inc.
+77.76% 13.67B
PURE HEALTH HOLDING Stock Pure Health Holding
-25.61% 12.83B
Other Healthcare Facilities & Services
  1. Stock Market
  2. Equities
  3. MD Stock
  4. Financials Pediatrix Medical Group, Inc.